Grace Therapeutics: Opaleye buys 48,060 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Grace Therapeutics, Inc. (GRCE) shares were purchased by Opaleye, L.P. in three transactions totaling 48,060 common shares: 15,879 on November 16, 2026, at a weighted average of $1.7641 per share; 29,207 on November 17 at $1.7219; and 2,974 on November 18 at $1.7254. The fund directly owns the shares. Opaleye Management Inc., the reporting person and investment manager identified as a 10% owner, may be deemed to beneficially own them but disclaims beneficial ownership except to the extent of its pecuniary interest. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, par value $0.0001 per share F4, F1, F5 | 2,974 | $1.7254 | $5K |
| Purchase | Common Stock, par value $0.0001 per share F3, F1, F5 | 29,207 | $1.7219 | $50K |
| Purchase | Common Stock, par value $0.0001 per share F2, F1, F5 | 15,879 | $1.7641 | $28K |
Footnotes (5)
- F1. Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
- F2. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.745 to $1.79. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.
- F3. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.675 to $1.75. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.
- F4. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.72 to $1.74. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.
- F5. Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Key Figures
Key Terms
weighted average price financial
beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were the price ranges for Opaleye, L.P.’s GRCE purchases?
AI-generated analysis. How Rhea-AI works. Not financial advice.